Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment

Eur J Anaesthesiol. 2004 Jul;21(7):572-4. doi: 10.1017/s0265021504227120.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Biomarkers / blood
  • Creatine Kinase / blood*
  • Fatigue / chemically induced
  • Genetic Predisposition to Disease
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Malignant Hyperthermia / diagnosis*
  • Malignant Hyperthermia / genetics
  • Middle Aged
  • Muscle Cramp / diagnosis
  • Pedigree

Substances

  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Creatine Kinase